$LFVN
Lifevantage Corp Stock $lfvn

$lfvn Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000084914624000121 Filed on October 29, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$47.21M
YoY Change		-8.08%
Cost Of Revenue		$9.491M
YoY Change		-6.77%
Gross Profit		$37.72M
YoY Change		-8.4%
Gross Profit Margin		79.9%
Selling, General & Admin		$14.85M
YoY Change		-17.34%
% of Gross Profit		39.36%
Research & Development		$300.0K
YoY Change		50.0%
% of Gross Profit		0.8%
Depreciation & Amortization		$797.0K
YoY Change		-13.18%
% of Gross Profit		2.11%
Operating Expenses		$35.15M
YoY Change		-13.06%
Operating Profit		$2.570M
YoY Change		243.12%
Interest Expense		$59.00K
YoY Change		-15.71%
% of Operating Profit		2.3%
Other Income/Expense, Net		$8.000K
YoY Change		-90.0%
Pretax Income		$2.578M
YoY Change		210.98%
Income Tax		$800.0K
% Of Pretax Income		31.03%
Net Earnings		$1.826M
YoY Change		190.3%
Net Earnings / Revenue		3.87%
Basic Earnings Per Share		$0.15
Diluted Earnings Per Share		$0.14
COMMON SHARES
Basic Shares Outstanding	12.53M shares	12.48M shares
Diluted Shares Outstanding		12.82M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$14.60M
YoY Change		-20.72%
Cash & Equivalents		$14.60M
Short-Term Investments
Other Short-Term Assets		$3.451M
YoY Change		-32.86%
Inventory		$16.91M
Prepaid Expenses
Receivables		$2.968M
Other Receivables		$886.0K
Total Short-Term Assets		$38.82M
YoY Change		-7.36%
LONG-TERM ASSETS
Property, Plant & Equipment		$7.477M
YoY Change		-19.69%
Goodwill
YoY Change
Intangibles		$290.0K
YoY Change		-31.28%
Long-Term Investments
YoY Change
Other Assets		$685.0K
YoY Change		43.91%
Total Long-Term Assets		$22.65M
YoY Change		-8.33%
TOTAL ASSETS
Total Short-Term Assets		$38.82M
Total Long-Term Assets		$22.65M
Total Assets		$61.46M
YoY Change		-7.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$5.270M
YoY Change		-22.08%
Accrued Expenses		$16.75M
YoY Change		2.1%
Deferred Revenue		$1.100M
YoY Change		10.0%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$22.07M
YoY Change		-10.64%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$225.0K
YoY Change		49.01%
Total Long-Term Liabilities		$225.0K
YoY Change		49.01%
TOTAL LIABILITIES
Total Short-Term Liabilities		$22.07M
Total Long-Term Liabilities		$225.0K
Total Liabilities		$33.76M
YoY Change		-9.51%
SHAREHOLDERS EQUITY
Retained Earnings		-$108.5M
YoY Change		4.35%
Common Stock		$137.3M
YoY Change		1.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$27.70M
YoY Change
Total Liabilities & Shareholders Equity		$61.46M
YoY Change		-7.72%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$1.826M
YoY Change		190.3%
Depreciation, Depletion And Amortization		$797.0K
YoY Change		-13.18%
Cash From Operating Activities		-$583.0K
YoY Change		-112.24%
INVESTING ACTIVITIES
Capital Expenditures		$349.0K
YoY Change		-69.2%
Acquisitions
YoY Change
Other Investing Activities		$4.000K
YoY Change
Cash From Investing Activities		-$345.0K
YoY Change		-69.55%
FINANCING ACTIVITIES
Cash Dividend Paid		$500.0K
YoY Change		-90.96%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$1.828M
YoY Change		-72.59%
NET CHANGE
Cash From Operating Activities		-$583.0K
Cash From Investing Activities		-$345.0K
Cash From Financing Activities		-$1.828M
Net Change In Cash		-$2.290M
YoY Change		-28.44%
FREE CASH FLOW
Cash From Operating Activities		-$583.0K
Capital Expenditures		$349.0K
Free Cash Flow		-$932.0K
YoY Change		-125.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12510000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12510000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	137347000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	136644000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108526000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108738000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1125000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1916000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	27697000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	25991000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61460000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60299000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47214000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10180000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	37723000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	41184000	usd
CY2024Q3	lfvn	Commission And Incentives CommissionAndIncentives	20305000	usd
CY2023Q3	lfvn	Commission And Incentives CommissionAndIncentives	22473000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14848000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17962000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	35153000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	40435000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2570000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	749000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-88000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2578000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	829000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12162000	shares
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	335000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	25991000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	917000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	797000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	917000	usd
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000849146
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	LIFEVANTAGE CORP
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0224471
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	3300 Triumph Blvd
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Lehi
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
CY2024Q3	dei	City Area Code CityAreaCode	801
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	432-9000
CY2024Q3	dei	Trading Symbol TradingSymbol	LFVN
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Inventory Net InventoryNet	16914000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2443000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	38815000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	37646000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	323000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4784000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4268000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	685000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	680000	usd
CY2024Q3	us-gaap	Assets Assets	61460000	usd
CY2024Q2	us-gaap	Assets Assets	60299000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5270000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5853000	usd
CY2024Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	6530000	usd
CY2024Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	6569000	usd
CY2024Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	47000	usd
CY2024Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	202000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1897000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1811000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8328000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7874000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	22072000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	22309000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	34308000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12484000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12484000	shares
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12525229	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14596000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16886000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2968000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2949000	usd
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	886000	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	313000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15055000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3451000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7477000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7813000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9409000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9569000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	290000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11466000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11801000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	225000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	198000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	33763000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51364000	usd
CY2024Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9491000	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	59000	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	168000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	752000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1826000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12537000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12824000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13109000	shares
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	791000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-294000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	791000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-294000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2617000	usd
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	347000	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1114000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	133000	usd
CY2024Q3	us-gaap	Dividends Cash DividendsCash	500000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	791000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1826000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	27697000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	34649000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	978000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	465000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	795000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	126000	usd
CY2023Q3	us-gaap	Dividends Cash DividendsCash	5534000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-294000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29294000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1826000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	918000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	978000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	353000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	216000	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4000	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2024Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8000	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-515000	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1703000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-81000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	922000	usd
CY2024Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	573000	usd
CY2023Q3	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-92000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1503000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-180000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	987000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	395000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-33000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-83000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-617000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3140000	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-155000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1522000	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	205000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	98000	usd
CY2024Q3	lfvn	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-449000	usd
CY2023Q3	lfvn	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-243000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2023Q3	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	172000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-583000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4765000	usd
CY2024Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	349000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1133000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-345000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1133000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1114000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	795000	usd
CY2024Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	500000	usd
CY2023Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	5534000	usd
CY2024Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	347000	usd
CY2023Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	465000	usd
CY2024Q3	lfvn	Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan	133000	usd
CY2023Q3	lfvn	Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan	126000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1828000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6668000	usd
CY2024Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	466000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-164000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2290000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3200000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16886000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21605000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14596000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18405000	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	8000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	1999000	usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	168000	usd
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America ("GAAP"). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div>
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-40000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	usd
CY2024Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </span>such risk. Financial instruments with significant credit risk include cash and investments.
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14167000	usd
CY2024Q3	lfvn	Inventory Finished Goods Percent Of Total Inventory InventoryFinishedGoodsPercentOfTotalInventory	0.838
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11841000	usd
CY2024Q2	lfvn	Inventory Finished Goods Percent Of Total Inventory InventoryFinishedGoodsPercentOfTotalInventory	0.787
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	2747000	usd
CY2024Q3	lfvn	Raw Materials Percent Of Total Inventory RawMaterialsPercentOfTotalInventory	0.162
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	3214000	usd
CY2024Q2	lfvn	Raw Materials Percent Of Total Inventory RawMaterialsPercentOfTotalInventory	0.213
CY2024Q3	us-gaap	Inventory Net InventoryNet	16914000	usd
CY2024Q3	lfvn	Inventory Percent Of Total Inventory InventoryPercentOfTotalInventory	1.000
CY2024Q2	us-gaap	Inventory Net InventoryNet	15055000	usd
CY2024Q2	lfvn	Inventory Percent Of Total Inventory InventoryPercentOfTotalInventory	1.000
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1000000.0	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1300000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1100000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	900000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-200000	usd
CY2024Q3	lfvn	Money Back Guarantee Period MoneyBackGuaranteePeriod	P30D
CY2024Q3	lfvn	Money Back Guarantee Period MoneyBackGuaranteePeriod	P30D
CY2024Q3	lfvn	Contracts With Customers Return Period For Resalable And Restockable Items ContractsWithCustomersReturnPeriodForResalableAndRestockableItems	P12M
CY2024Q3	lfvn	Contracts With Customers Refund Percent For Resalable And Restockable Items ContractsWithCustomersRefundPercentForResalableAndRestockableItems	1
CY2024Q3	lfvn	Handling And Restocking Fee Percentage HandlingAndRestockingFeePercentage	0.10
CY2024Q3	lfvn	Return Liability Reserve ReturnLiabilityReserve	100000	usd
CY2024Q2	lfvn	Return Liability Reserve ReturnLiabilityReserve	100000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	300000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	200000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	1826000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	629000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12162000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12537000	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	662000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	572000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12824000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13109000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q3	lfvn	Number Of Geographic Segments NumberOfGeographicSegments	2	region
CY2024Q3	lfvn	Number Of Geographic Segments NumberOfGeographicSegments	2	region
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47214000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51364000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M13D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0346
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0346
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	600000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	470000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	530000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	41000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	48000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	516000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	590000	usd
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	530000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	557000	usd
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1502000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1631000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2210000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2202000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2076000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1772000	usd
CY2024Q3	lfvn	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	4622000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14513000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1150000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	13363000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000.0	usd
CY2022Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	60000000.0	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000	shares
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1100000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000	shares
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	800000	usd
CY2024Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	19300000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	20
CY2023Q3	lfvn	Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable	0.12
CY2023Q3	lfvn	Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable Passive Investors ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors	0.20
CY2023Q3	lfvn	Class Of Warrants Or Right Discount ClassOfWarrantsOrRightDiscount	0.50
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.04
CY2024Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	500000	usd
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5500000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.435
CY2024Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	22000	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	39000	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1000000.0	usd
CY2024Q3	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of September 30, 2024, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000849146-24-000121-index-headers.html	Edgar Link	pending
0000849146-24-000121-index.html	Edgar Link	pending
0000849146-24-000121.txt	Edgar Link	pending
0000849146-24-000121-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lfvn-20240930.htm	Edgar Link	pending
lfvn-20240930.xsd	Edgar Link	pending
lfvn_93024xex311.htm	Edgar Link	pending
lfvn_93024xex312.htm	Edgar Link	pending
lfvn_93024xex321.htm	Edgar Link	pending
lfvn_93024xex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lfvn-20240930_cal.xml	Edgar Link	unprocessable
lfvn-20240930_def.xml	Edgar Link	unprocessable
lfvn-20240930_lab.xml	Edgar Link	unprocessable
lfvn-20240930_pre.xml	Edgar Link	unprocessable
lfvn-20240930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFVN
Lifevantage Corp Stock $lfvn

2024 Q4 Form 10-Q Financial Statement

#000084914624000121 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN Lifevantage Corp Stock $lfvn

2024 Q4 Form 10-Q Financial Statement

#000084914624000121 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN
Lifevantage Corp Stock $lfvn